Equity Capital Markets

Company · CIK 2114044

Hemab Therapeutics Holdings, Inc.

CIK2114044 (SEC EDGAR)
Industry (SIC)2836 — Biological Products, (No Diagnostic Substances)
Incorporated inDE
Business addressMA
ListedCOAG (Nasdaq)
First annual or quarterly report2026-05-21

Offerings

1 registration
RegistrationLabel and statusFirst filedLast eventFilings
333-294989
IPOFinal prospectus
 2026-04-102026-05-016

Filings

7
FiledFilingRegistrationAccession
2026-05-01424B4Final prospectus 333-2949890001193125-26-201458
2026-04-30EFFECTDeclared effective 333-2949899999999995-26-001409
2026-04-30S-1/AAmendment 333-2949890001193125-26-193885
2026-04-28S-1/AAmendment 333-2949890001193125-26-186964
2026-04-27S-1/AAmendment 333-2949890001193125-26-178809
2026-04-10S-1Registration filed 333-2949890001193125-26-151378
2026-02-27DRSDraft made public 377-091050001193125-26-081986

All filings of this company · CSV